Skip to main navigation Skip to search Skip to main content

IgE in the human placenta: Why there?

  • E. Rindsjö*
  • , M. Joerink
  • , N. Papadogiannakis
  • , A. Scheynius
  • *Corresponding author for this work
  • Clinical Allergy Research Unit
  • Karolinska Institutet

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Immunoglobulin E (IgE) antibodies are key effector molecules in the allergic inflammatory response and are also involved in the protection against extracellular parasites. Allergic symptoms often develop early in life, and the intrauterine environment has been proposed to play an important role in affecting the risk of later allergy development. The placenta constitutes a selective barrier between the maternal and foetal circulation. Recently, we reported that maternal IgE antibodies are present on foetal macrophages in the villous tissue of the human placenta irrespective of maternal allergy status. This review discusses the presence of IgE antibodies in the human placenta and its possible roles in normal and pathologic pregnancy. It also deals with the relationship between placental IgE and development of allergy during childhood. A better understanding of the role of IgE in placenta could give us clues on how to prevent allergy development in the future generations. © 2010 John Wiley & Sons A/S.
Original languageEnglish
Pages (from-to)554-560
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume65
Issue number5
DOIs
Publication statusPublished - May 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'IgE in the human placenta: Why there?'. Together they form a unique fingerprint.

Cite this